- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x E4Z: Baloxavir acid(Non-covalent)
- 4 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
QQ4.2: 5 residues within 4Å:- Chain A: M.32, F.66, I.79, G.82, R.83
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.66, A:I.79
QQ4.12: 5 residues within 4Å:- Chain B: M.32, F.66, I.79, G.82, R.83
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.66, B:I.79
QQ4.22: 5 residues within 4Å:- Chain C: M.32, F.66, I.79, G.82, R.83
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:F.66, C:I.79
QQ4.32: 5 residues within 4Å:- Chain D: M.32, F.66, I.79, G.82, R.83
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:F.66, D:I.79
- 20 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 4 residues within 4Å:- Chain A: G.72, S.73, R.76, K.114
Ligand excluded by PLIPGOL.4: 2 residues within 4Å:- Chain A: W.89, K.103
Ligand excluded by PLIPGOL.5: 2 residues within 4Å:- Chain A: K.135
- Ligands: E4Z.1
Ligand excluded by PLIPGOL.6: 6 residues within 4Å:- Chain A: I.80, E.81, G.82, R.83, A.88
- Ligands: E4Z.1
Ligand excluded by PLIPGOL.7: 6 residues within 4Å:- Chain A: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPGOL.13: 4 residues within 4Å:- Chain B: G.72, S.73, R.76, K.114
Ligand excluded by PLIPGOL.14: 2 residues within 4Å:- Chain B: W.89, K.103
Ligand excluded by PLIPGOL.15: 2 residues within 4Å:- Chain B: K.135
- Ligands: E4Z.11
Ligand excluded by PLIPGOL.16: 6 residues within 4Å:- Chain B: I.80, E.81, G.82, R.83, A.88
- Ligands: E4Z.11
Ligand excluded by PLIPGOL.17: 6 residues within 4Å:- Chain B: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPGOL.23: 4 residues within 4Å:- Chain C: G.72, S.73, R.76, K.114
Ligand excluded by PLIPGOL.24: 2 residues within 4Å:- Chain C: W.89, K.103
Ligand excluded by PLIPGOL.25: 2 residues within 4Å:- Chain C: K.135
- Ligands: E4Z.21
Ligand excluded by PLIPGOL.26: 6 residues within 4Å:- Chain C: I.80, E.81, G.82, R.83, A.88
- Ligands: E4Z.21
Ligand excluded by PLIPGOL.27: 6 residues within 4Å:- Chain C: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPGOL.33: 4 residues within 4Å:- Chain D: G.72, S.73, R.76, K.114
Ligand excluded by PLIPGOL.34: 2 residues within 4Å:- Chain D: W.89, K.103
Ligand excluded by PLIPGOL.35: 2 residues within 4Å:- Chain D: K.135
- Ligands: E4Z.31
Ligand excluded by PLIPGOL.36: 6 residues within 4Å:- Chain D: I.80, E.81, G.82, R.83, A.88
- Ligands: E4Z.31
Ligand excluded by PLIPGOL.37: 6 residues within 4Å:- Chain D: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIP- 8 x MN: MANGANESE (II) ION(Non-covalent)
MN.8: 6 residues within 4Å:- Chain A: H.61, D.109, D.120, I.121
- Ligands: E4Z.1, MN.9
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:H.61, A:D.109, A:I.121
MN.9: 5 residues within 4Å:- Chain A: H.61, E.81, D.109
- Ligands: E4Z.1, MN.8
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.81, A:D.109, H2O.1, H2O.1
MN.18: 6 residues within 4Å:- Chain B: H.61, D.109, D.120, I.121
- Ligands: E4Z.11, MN.19
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:H.61, B:D.109, B:I.121
MN.19: 5 residues within 4Å:- Chain B: H.61, E.81, D.109
- Ligands: E4Z.11, MN.18
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.81, B:D.109, H2O.2, H2O.3
MN.28: 6 residues within 4Å:- Chain C: H.61, D.109, D.120, I.121
- Ligands: E4Z.21, MN.29
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:H.61, C:D.109, C:I.121
MN.29: 5 residues within 4Å:- Chain C: H.61, E.81, D.109
- Ligands: E4Z.21, MN.28
4 PLIP interactions:2 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.81, C:D.109, H2O.4, H2O.4
MN.38: 6 residues within 4Å:- Chain D: H.61, D.109, D.120, I.121
- Ligands: E4Z.31, MN.39
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:H.61, D:D.109, D:I.121
MN.39: 5 residues within 4Å:- Chain D: H.61, E.81, D.109
- Ligands: E4Z.31, MN.38
4 PLIP interactions:2 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:E.81, D:D.109, H2O.6, H2O.6
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.10: 4 residues within 4Å:- Chain A: Y.44, R.85, W.89
- Ligands: E4Z.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.89
- Salt bridges: A:R.85
SO4.20: 4 residues within 4Å:- Chain B: Y.44, R.85, W.89
- Ligands: E4Z.11
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.89
- Salt bridges: B:R.85
SO4.30: 4 residues within 4Å:- Chain C: Y.44, R.85, W.89
- Ligands: E4Z.21
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:W.89
- Salt bridges: C:R.85
SO4.40: 4 residues within 4Å:- Chain D: Y.44, R.85, W.89
- Ligands: E4Z.31
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:W.89
- Salt bridges: D:R.85
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kumar, G. et al., Structural insights into the substrate specificity of the endonuclease activity of the influenza virus cap-snatching mechanism. Nucleic Acids Res. (2021)
- Release Date
- 2021-02-03
- Peptides
- Protein PA-X: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x E4Z: Baloxavir acid(Non-covalent)
- 4 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
- 20 x GOL: GLYCEROL(Non-functional Binders)
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kumar, G. et al., Structural insights into the substrate specificity of the endonuclease activity of the influenza virus cap-snatching mechanism. Nucleic Acids Res. (2021)
- Release Date
- 2021-02-03
- Peptides
- Protein PA-X: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A